BOT 0.00% 32.0¢ botanix pharmaceuticals ltd

FDA approves Winlevi, page-7

  1. 2,832 Posts.
    lightbulb Created with Sketch. 603
    It depends on the size of the market - if the market is saved by destroying it then it isn't worth a Brass Razoo.

    If BTX 1801 is a success then, assuming a successful Phase 3, BTX 1503 is "worth" more.

    I think BOT is worth 40 cent/share now and > $1.00 after a successful Phase 3, regardless of BTX 1801.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.000(0.00%)
Mkt cap ! $581.5M
Open High Low Value Volume
32.5¢ 32.5¢ 31.5¢ $1.940M 6.061M

Buyers (Bids)

No. Vol. Price($)
17 470483 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 33000 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.